fostamatinib disodium | |
---|---|
Trade Name | |
Orphan Indication | Immune thrombocytopenic purpura |
USA Market Approval | USA |
USA Designation Date | 2015-08-25 00:00:00 |
Sponsor | Rigel Pharmaceuticals, Inc.;1180 Veterans Boulevard;South San Francisco, California, 94080 |